Transgene Announces Upcoming Investor Meetings

On September 9, 2020 Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, reported that Management will participate in the upcoming investor events set out below (Press release, Transgene, SEP 9, 2020, View Source [SID1234564864]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H. C. Wainwright Annual Global Investment Conference: September 14 to 16, 2020 – Virtual event
Portzamparc Biotech Conference: October 1 & 2, 2020 – Virtual event
HealthTech Investor Day by France Biotech: October 5 & 6, 2020 – Hybrid event (Virtual and Paris, France)
European Midcap Event: October 19 & 20, 2020 – Hybrid event (Virtual and Paris, France)
Bryan Garnier & Co European Healthcare Conference: November 16 & 17, 2020 – Virtual event
Jefferies Virtual Global Healthcare Conference: November 17-19, 2020 – Virtual event